Cargando…

Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein

OBJECTIVE: To analyze the clinical effect of compound ipratropium bromide combined with budesonide atomization inhalation on acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and its effect on the heparin-binding protein. METHODS: A total of 110 patients with AECOPD who were admit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yuan, Li, Qingling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273349/ https://www.ncbi.nlm.nih.gov/pubmed/35832532 http://dx.doi.org/10.1155/2022/4457740

Ejemplares similares

The Effect of Ipratropium Bromide with Violet Flower Extract, Ipratropium Bromide with Budesonide, and Ipratropium Bromide Alone on the Cuff-Leak of the Endotracheal Tube in Intubated ICU Patients
por: Hashemi, Seyed Taghi, et al.
Publicado: (2023)

Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease
por: Panos, Ralph J
Publicado: (2013)

Use of inhaled ipratropium bromide to improve exercise-induced laryngeal obstruction cannot be recommended
por: Muralitharan, Praveen, et al.
Publicado: (2023)

Bioequivalence study of ipratropium bromide inhalation aerosol using PBPK modelling
por: Zhang, Jisheng, et al.
Publicado: (2023)

Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease
por: Li, Xuan, et al.
Publicado: (2017)

Aerosol Characteristics and Physico-Chemical Compatibility of Combivent(®) (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine
por: Zhang, Rui, et al.
Publicado: (2020)

The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China
por: Huang, Kewu, et al.
Publicado: (2019)

Bromangiomas-ipratropium bromide–associated angiomas
por: Samlaska, Curt, et al.
Publicado: (2019)

Compatible Stability and Aerosol Characteristics of Atrovent(®) (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
por: Chen, Yiting, et al.
Publicado: (2020)

Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2018)

Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease
por: Ye, Wen-Yi, et al.
Publicado: (2023)

Rare causes of anisocoria: Ipratropium bromide and Angel’s trumpet
por: Ekici, Arzu, et al.
Publicado: (2021)

Application Value of Blood Heparin-Binding Protein in the Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Dong, Yuan, et al.
Publicado: (2021)

Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered‐Dose Inhaler
por: MacGregor, TR, et al.
Publicado: (2016)

Transient anisocoria in a patient treated with nebulized ipratropium bromide
por: Pejic, Renato, et al.
Publicado: (2017)

Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
por: Bhattacharya, Amal, et al.
Publicado: (2016)

Unilateral mydriasis secondary to ipratropium bromide in a critically ill patient
por: Santana-Cabrera, Luciano, et al.
Publicado: (2012)

Clinical effects of lentinan combined with budesonide inhalation in treating acute exacerbation of chronic obstructive pulmonary disease under mechanical ventilation
por: Sun, Jian, et al.
Publicado: (2019)

Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhang, Rui, et al.
Publicado: (2020)

Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis
por: Xu, Hongzhen, et al.
Publicado: (2021)

Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease
por: Zhao, Daguo, et al.
Publicado: (2018)

Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015)

Airway hygiene in the ICU: can ipratropium plus salbutamol help?
por: Magalhaes, N
Publicado: (2015)

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain
por: Rutten-van Mölken, Maureen P. M. H., et al.
Publicado: (2007)

Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting
por: Gauhar, Umair, et al.
Publicado: (2009)

Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
por: Haney, Sarah, et al.
Publicado: (2007)

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study
por: Ferguson, Gary T, et al.
Publicado: (2013)

Ipratropium bromide is more effective than Salmeterol — Fluticason combination on O(2) saturation patients with COPD
por: Rezaie, Nader, et al.
Publicado: (2013)

Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease
por: Fahim, Ahmed, et al.
Publicado: (2012)

The Combination of Tiotropium and Budesonide in the Treatment of Chronic Obstructive Pulmonary Disease
por: Um, Sang-Won, et al.
Publicado: (2007)

Nebulized Ipratropium bromide protects against tracheal and bronchial secretion during bronchoscopy: A randomized controlled trial
por: Wang, Faping, et al.
Publicado: (2019)

Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
por: Naveed, Hina, et al.
Publicado: (2023)

Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD
por: De Backer, LA, et al.
Publicado: (2011)

Unilateral pupillary mydriasis from nebulized ipratropium bromide: A false sign of brain herniation in the intensive care unit
por: Chaudhry, Priyanka, et al.
Publicado: (2014)

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
por: Donohue, James F., et al.
Publicado: (2016)

Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: A nationwide multicenter retrospective study
por: Du, Zhuoying, et al.
Publicado: (2020)

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease
por: Gu, Yong-Li, et al.
Publicado: (2022)

Comparative Efficacy of Budesonide/Formoterol with Budesonide, Formoterol or Placebo for Stable Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Tang, Bin, et al.
Publicado: (2019)

Inhaler Technique and Adherence to Inhaled Medications among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam
por: Ngo, Chau Quy, et al.
Publicado: (2019)

The rapid effects of budesonide plus formoterol in patients with obstructive airway diseases
por: Bayiz, Hulya, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0rh3dtsr10f5igltd9i1m54dkb